Hem › Vaso-ocklusiva kriser › Georgia
Kliniska studier för Vaso-ocklusiva kriser i Georgia
4 studier för Vaso-ocklusiva kriser söker deltagare vid platser i Georgia.
Städer i Georgia
Officiell studietext (engelska)
A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)
- Augusta University Georgia, Augusta
- WCG Sonar Clinical Research, Riverdale
RekryterarFas 3
Ålder 12 till 100 · Alla kön · Uppdaterad 28 sep. 2026 · NCT06439082Safety, Efficacy, and Pharmacokinetics of CSL889 in Adults and Adolescents With Sickle Cell Disease During Vaso-Occlusive Crisis
- Arthur M. Blank Hospital-Children's Healthcare of Atlanta, Atlanta
RekryterarFas 2
Ålder 12 och äldre · Alla kön · Uppdaterad 14 aug. 2026 · NCT06699849Safety of Anumigilimab (CSL324) in Adults With Sickle Cell Disease (SCD)
- Arthur M. Blank Hospital- Children's Healthcare of Atlanta, Atlanta
RekryterarFas 2
Ålder 18 och äldre · Alla kön · Uppdaterad 5 aug. 2026 · NCT07224360Rollover Study for Patients With Sickle Cell Disease Who Have Completed a Prior Novartis-Sponsored Crizanlizumab Study
- Augusta University Georgia, Augusta
RekryterarFas 4
6 Months – 100 Years · Alla kön · Uppdaterad 8 juni 2026 · NCT04657822Från ClinicalTrials.gov, data hämtad 5 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.